Cochlear implantation in infants below 12 months of age

Area of Science:

• Pediatric Otolaryngology
• Developmental Pediatrics
• Auditory Neuroscience

Background:

• Newborn hearing screening identifies deafness early, making cochlear implantation a critical intervention when hearing aids fail.
• Early cochlear implantation is crucial as age at implantation significantly impacts language outcomes.
• Current FDA guidelines previously excluded infants under 12 months, necessitating further safety and efficacy research.

Purpose of the Study:

• To evaluate the safety and efficacy of cochlear implantation in infants younger than 12 months.
• To gather long-term language development data for this pediatric cohort.
• To assess the feasibility of using a minimally invasive surgical technique in very young children.

Main Methods:

• A prospective clinical trial involving infants under 12 months who failed hearing aid trials.
• Use of a preferential listening paradigm to assess speech sound-object association learning.
• Long-term language assessments, including the Peabody Picture Vocabulary Test (PPVT).

Main Results:

• No surgical or anesthetic complications were reported in the study cohort.
• Infants demonstrated listening skill development comparable to normal-hearing peers.
• Long-term data indicated that many infants achieved age-appropriate language skills.

Conclusions:

• Cochlear implantation in infants under 12 months is a safe and effective procedure.
• Early implantation supports the development of age-appropriate language skills, as evidenced by PPVT results.
• This study supports expanding cochlear implantation candidacy to younger infants.